Should GLP1 R agonists be used as first line glucose lowering agents in patients with ESKD and DM2?
Answer from: at Academic Institution
This is a great question, but like all clinical questions the answer will be "it depends". A provider considering adding a new drug for DM2 in a patient with CKD5/dialysis would need to know several specifics about the patient. Let's say, the patient is not on any DM2 medication. Is this an older, t...
Comments
at Lebauer Endocrinology For stages 3-4, sglt2 drugs are preferred especial...
at Northwestern University Endocrinology With Stage 3-4 CKD, SGLT2 inhibitors have a signif...
For stages 3-4, sglt2 drugs are preferred especial...
With Stage 3-4 CKD, SGLT2 inhibitors have a signif...